Comments
Loading...
Moderna (NASDAQ:MRNA) Stock Quotes, Forecast and News Summary
Moderna Stock (NASDAQ: MRNA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Moderna (MRNA) stock?
You can purchase shares of Moderna (NASDAQ:MRNA) through any online brokerage.
Who are Moderna (MRNA) competitors?
Other companies in Moderna’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Moderna (MRNA) stock?
Moderna has a consensus price target of $97.90.
What is the current price for Moderna (MRNA)?
The stock price for Moderna (NASDAQ: MRNA) is $36.37 last updated November 21, 2024 at 9:31 AM EST.
Does Moderna (MRNA) pay a dividend?
There are no upcoming dividends for Moderna.
When is Moderna (NASDAQ:MRNA) reporting earnings?
Moderna’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Moderna (MRNA) going to split?
There is no upcoming split for Moderna.
What sector and industry does Moderna (MRNA) operate in?
Moderna is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.